Please Note: This trial is no longer enrolling new participants
PHASE 1B STUDY OF REGN5458 (ANTI-BCMA X ANTICD3 BISPECIFIC ANTIBODY) PLUS OTHER CANCER TREATMENTS FOR PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
Protocol No. | CTO-R5458-ONC-2012 | Scope | National |
---|---|---|---|
Principal Investigator | Attaya Suvannasankha | Treatment Type | Treatment |
Age Group | Adult | Phase | Phase I |